Catheters Market Top Players - Abbott Laboratories, B Braun, Boston Scientific Corporation, Coloplast, ConvaTec Inc., Cure Medical, Edwards Life Sciences Corporation, Hollister Incorporated, Johnson and Johnson, Manfred Sauer, Medtronic Inc., Smiths Medic

Catheters market is expected to exceed USD 79 billion by 2025. The increasing prevalence of cardiovascular, neurological and urological disease worldwide will drive catheters market growth over the analysis timeframe.

Some major findings of the catheters market report include:
o Catheter is a rigid or flexible hollow tube used to drain fluids from body cavities or to enlarge body passages
o Increase in prevalence of cardiovascular & urological disorders in developed as well as developing economies will increase the demand for catheter-based procedures
o Introduction of advanced catheters will ease the surgical procedures, reduce treatment time and assist in minimally invasive procedures, thus, leading to surge in market
o Hospitals facilitated with ambulatory catheterization labs delivering top class outpatient services will accelerate the market expansion
o Growing number of catheterization procedures in Asia Pacific will eventually upsurge the demand for catheters, thereby fostering regional growth over the coming years

Request sample copy of this report @ https://www.decresearch.com/request-sample/detail/787?utm_source=open&utm_medium=vsm

Technological advancements in catherization such as precise lesions, flexibility and extended instrument capability is anticipated to propel catheters market growth over the analysis period. Moreover, introduction of new antimicrobial coated and navigation-enabled ablation catheters for electrophysiology process will increase its adoption, thereby augmenting the business growth.

Additionally, surge in adoption of hydrophilic, PTFE, pro slit covered tip and other advanced catheter technologies will prove beneficial for the market growth. For instance, Mariner hydrophilic-coated angiographic catheter features duration coating technology, aids smooth navigation and reduces catheter surface friction. Hence, accessibility to such technological advanced products should foster the overall catheters market growth. However, high cost associated with catheters may impede the market growth in developing and underdeveloped countries.

Catheters market is segmented based on product, lumen and end-use. The product segment includes vascular, urology, intravenous and specialty catheters. Vascular segment is further divided into cardiovascular & neurovascular catheters.

Make Inquiry about this report @ https://www.decresearch.com/inquiry-before-buying/787?utm_source=open&utm_medium=vsm

Neurovascular segment was valued around USD 2 billion in 2018 and is projected to witness lucrative growth during the analysis period. Considerable rise in prevalence of ischemic strokes, brain aneurysm and other neurological disorders will augment the need for effective treatment, thereby boosting the segmental growth. Moreover, associated benefits of neurovascular catheters such as flexibility, safe navigation of the intracranial system among others will further upsurge the product adoption.
Aforementioned factors are thus expected to accelerate the demand for neurovascular catheters worldwide.

Lumen segment includes single-lumen, double-lumen, triple-lumen and others. The double-lumen segment is poised to witness around 11.5% CAGR during the forecast timeline. Dual lumen catheter is enabled with two channels, one for injection & other for removal of fluids that facilitates various thoracic procedures. Moreover, rising patient preference for peripheral & interventional surgical procedures along with wide application of double-lumen venous, urological & drainage catheters will further propel the segmental growth.

End-use segment covers hospitals & clinics, specialty centers, ambulatory surgical care centers (ASCs) and others. Hospitals & clinics segment is anticipated to account for more than 32% revenue share by 2025. The growth is attributed to technological advances coupled with favorable reimbursement policies in hospitals. Furthermore, well-developed healthcare infrastructure and availability of advanced treatments will boost hospitals segmental growth in the upcoming years.
U.S. catheters market accounted for around USD 11.9 billion in 2018. Growing adoption of non-invasive surgical procedures coupled with growing demand for advanced medical treatments will positively influence the market expansion. Increasing healthcare spending on advanced medical treatments and strong foothold of key market players in the U.S. will escalate product adoption, thereby driving the industry progress.

Some of the notable industry players operating in the catheters market are: Abbott Laboratories, B Braun, Boston Scientific Corporation, Coloplast, ConvaTec, Cure Medical, Edwards Life Sciences Corporation, Hollister Incorporated, Johnson and Johnson, Manfred Sauer, Medtronic, Smiths Medical, Stryker Corporation, Teleflex and Wellspect Healthcare among others. The business players focus on numerous inorganic and organic growth strategies to sustain market competition. For instance, in March 2018, Smiths Medical announced the FDA clearance and U.S. launch of Delta Med closed system catheter. The new product launch helped the company in expanding its existing customer base and gain more revenue.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

This release was published on openPR.